The authors demonstrated that anti-tumor activity of CD28-CD3ζ CAR-T cells in the presence of Treg cells was less than that of CD3ζ-CAR-T cells against tumor CEA-overexpressing tumors [36]. The gene discussed is CD28; the disease is neoplasm.